biote Corp.

Haymaker Acquisition Corp. II, trading under the ticker HYAC, is a blank check company sponsored by Haymaker Sponsor II, LLC and focused on the healthcare and consumer wellness sector. The SPAC completed its initial public offering in 2020 and filed this Form 10-Q with the Securities and Exchange Commission on May 20, 2021, accession number 0001193125-21-167790, covering quarterly financial and operational disclosures. HYAC ultimately targeted biote Corp., a hormone health optimization company, in its de-SPAC combination. The filing reflects the company's status during its active deal pursuit and evaluation period. Sign up at SpacDesk for full filing history, deal timelines, and sponsor analytics on HYAC and hundreds of other SPACs.